Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Marsden

Showing results (661-670 of 1,050) with videos related to

Pageof 105
Sort By:
Advances in Neurology|July 20, 1999
Toxins, genetics, and Parkinson's disease: the role of N-acetyltransferase 2O Bandmann, J Vaughan, P A Holmans, et al.
Brain : a Journal of Neurology|June 1, 1996
Alterations in peptide levels in Parkinson's disease and incidental Lewy body diseaseA Fernandez, M L de Ceballos, S Rose, et al.
Annals of Neurology|March 1, 1992
A follow-up study of isolated cases of suspected Huntington's diseaseD Bateman, A M Boughey, F Scaravilli, et al.
Nature|April 8, 1982
Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatumK Murugaiah, A Theodorou, S Mann, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1984
Dopamine receptor binding sites in the rat superior colliculusJ K Chivers, M D Hall, E Kelly, et al.
Neuroscience Letters|July 19, 1988
Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicityJ Willoughby, V Glover, M Sandler, et al.
Journal of Neurology|February 1, 1992
Brain muscarinic cholinergic receptors in Huntington's diseaseK W Lange, F Javoy-Agid, Y Agid, et al.
Neuroscience Letters|March 20, 1987
Age-related decreases in the concentration of Met- and Leu-enkephalin and neurotensin in the basal ganglia of ratsM L De Ceballos, S Boyce, M Taylor, et al.
The Journal of Pharmacy and Pharmacology|June 1, 1988
Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptorsJ K Chivers, W Gommeren, J E Leysen, et al.
Lancet (London, England)|May 8, 1999
Overdiagnosis of essential tremorA Schrag, A Muenchau, K P Bhatia, et al.
Pageof 105

Showing results (661-670 of 1,050) with videos related to

Sort By:
Pageof 105
Advances in Neurology|July 20, 1999
Toxins, genetics, and Parkinson's disease: the role of N-acetyltransferase 2O Bandmann, J Vaughan, P A Holmans, et al.
Brain : a Journal of Neurology|June 1, 1996
Alterations in peptide levels in Parkinson's disease and incidental Lewy body diseaseA Fernandez, M L de Ceballos, S Rose, et al.
Annals of Neurology|March 1, 1992
A follow-up study of isolated cases of suspected Huntington's diseaseD Bateman, A M Boughey, F Scaravilli, et al.
Nature|April 8, 1982
Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatumK Murugaiah, A Theodorou, S Mann, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1984
Dopamine receptor binding sites in the rat superior colliculusJ K Chivers, M D Hall, E Kelly, et al.
Neuroscience Letters|July 19, 1988
Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicityJ Willoughby, V Glover, M Sandler, et al.
Journal of Neurology|February 1, 1992
Brain muscarinic cholinergic receptors in Huntington's diseaseK W Lange, F Javoy-Agid, Y Agid, et al.
Neuroscience Letters|March 20, 1987
Age-related decreases in the concentration of Met- and Leu-enkephalin and neurotensin in the basal ganglia of ratsM L De Ceballos, S Boyce, M Taylor, et al.
The Journal of Pharmacy and Pharmacology|June 1, 1988
Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptorsJ K Chivers, W Gommeren, J E Leysen, et al.
Lancet (London, England)|May 8, 1999
Overdiagnosis of essential tremorA Schrag, A Muenchau, K P Bhatia, et al.
Pageof 105